資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34682
|
| 標題: | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis |
| 作者: | Cheng, Kai-Wen
Tseng, Chih-Hua
Chen, I. -Ju
Huang, Bo-Cheng
Liu, Hui-Ju
Ho, Kai-Wen
Lin, Wen-Wei
Chuang, Chih-Hung
Huang, Ming-Yii
Leu, Yu-Lin
Roffler, Steve R.
Wang, Jaw-Yuan
Chen, Yeh-Long
Cheng, Tian-Lu |
| 貢獻者: | California Institute of Technology
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Municipal Ta-Tung Hospital
Kaohsiung Medical University
I Shou University
National Sun Yat Sen University
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University
Chia Nan University of Pharmacy & Science
Academia Sinica - Taiwan
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University
Kaohsiung Medical University |
| 關鍵字: | colorectal-cancer
colon carcinogenesis
mouse models
sequences
azoxymethane
communities
unifrac
silva
mice
risk |
| 日期: | 2022 |
| 上傳時間: | 2023-12-11 14:04:56 (UTC+8) |
| 出版者: | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| 摘要: | The bidirectional interaction between carcinogens and gut microbiota that contributes to colorectal cancer is complicated. Reactivation of carcinogen metabolites by microbial beta-glucuronidase (beta G) in the gut potentially plays an important role in colorectal carcinogenesis. We assessed the chemoprotective effects and associated changes in gut microbiota induced by pre-administration of bacterial-specific beta G inhibitor TCH-3511 in carcinogen azoxymethane (AOM)-treated APC(Min/+) mice. AOM induced intestinal beta G activity, which was reflected in increases in the incidence, formation, and number of tumors in the intestine. Notably, inhibition of gut microbial beta G by TCH-3511 significantly reduced AOM-induced intestinal beta G activity, decreased the number of polyps in both the small and large intestine to a frequency that was similar in mice without AOM exposure. AOM also led to lower diversity and altered composition in the gut microbiota with a significant increase in mucindegrading Akkermansia genus. Conversely, mice treated with TCH-3511 and AOM exhibited a more similar gut microbiota structure as mice without AOM administration. Importantly, TCH-3511 treatment significant decreased Akkermansia genus and produced a concomitant increase in short-chain fatty acid butyrate-producing gut commensal microbes Lachnoospiraceae NK4A136 group genus in AOM-treated mice. Taken together, our results reveal a key role of gut microbial beta G in promoting AOM-induced gut microbial dysbiosis and intestinal tumorigenesis, indicating the chemoprotective benefit of gut microbial beta G inhibition against carcinogens via maintaining the gut microbiota balance and preventing cancer-associated gut microbial dysbiosis. Thus, the bacterial-specific beta G inhibitor TCH-3511 is a potential chemoprevention agent for colorectal cancer. |
| 關聯: | PHARMACOLOGICAL RESEARCH, v.177, n.CB2, pp.CC2, pp.-, |
| 顯示於類別: | [行政單位] 123
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 75 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
